ORBIMED ADVISORS LLC Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$9.5B
Holdings
138
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (138 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | RAREULTRAGENYX PHARMACEUTICAL IN | 128,300 | $8.1B | 85.47% | |
| 102 | ENTAENANTA PHARMACEUTICALS INC | 249,400 | $7.3B | 77.08% | |
| 103 | —BIOTIE THERAPIES OYJ | 268,672 | $7.1B | 74.60% | |
| 104 | ASMBASSEMBLY BIOSCIENCES INC | 1,397,100 | $7.0B | 73.79% | |
| 105 | RDHLGBPREDHILL BIOPHARMA LTD | 564,900 | $6.9B | 72.81% | |
| 106 | —INCYTE CORP | 4,250,000 | $6.7B | 70.78% | |
| 107 | —INCYTE CORP | 4,250,000 | $6.6B | 69.17% | |
| 108 | —SYNERGY PHARMACEUTICALS DEL | 2,276,648 | $6.3B | 66.12% | |
| 109 | MGNXMACROGENICS INC | 317,000 | $5.9B | 62.54% | |
| 110 | —ADVAXIS INC | 636,600 | $5.7B | 60.48% | |
| 111 | QGENQIAGEN NV | 256,800 | $5.7B | 60.37% | |
| 112 | LAB 2.75 02/01/34FLUIDIGM CORP DEL | 10,000,000 | $5.6B | 58.43% | |
| 113 | —MARINUS PHARMACEUTICALS INC | 965,000 | $5.2B | 54.63% | |
| 114 | —LION BIOTECHNOLOGIES INC | 1,022,100 | $5.2B | 54.63% | |
| 115 | BHCVALEANT PHARMACEUTICALS INTL | 194,900 | $5.1B | 53.94% | |
| 116 | NVTA1EURINVITAE CORP | 456,666 | $4.7B | 49.16% | |
| 117 | —CONNECTURE INC | 1,740,000 | $4.5B | 46.87% | |
| 118 | MCRB1EURSERES THERAPEUTICS INC | 166,645 | $4.4B | 46.57% | |
| 119 | MRTXEURMIRATI THERAPEUTICS INC | 197,859 | $4.2B | 44.55% | |
| 120 | ASNDASCENDIS PHARMA A S | 222,223 | $4.1B | 43.37% | |
| 121 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 438,784 | $3.6B | 37.53% | |
| 122 | CERSCERUS CORP | 578,300 | $3.4B | 36.08% | |
| 123 | —MYLAN N V | 69,800 | $3.2B | 34.04% | |
| 124 | —ANACOR PHARMACEUTICALS INC | 53,300 | $2.8B | 29.98% | |
| 125 | —ALIMERA SCIENCES INC | 1,500,000 | $2.6B | 27.62% | |
| 126 | —ROKA BIOSCIENCE INC | 3,220,429 | $2.2B | 23.38% | |
| 127 | QUREUNIQURE NV | 184,800 | $2.2B | 23.10% | |
| 128 | —OREXIGEN THERAPEUTICS INC | 5,210,000 | $2.1B | 22.61% | |
| 129 | —MEDIGUS LTD | 600,000 | $1.6B | 16.92% | |
| 130 | —XTANT MED HLDGS INC | 475,439 | $1.3B | 13.55% | |
| 131 | FATEFATE THERAPEUTICS INC | 692,900 | $1.2B | 13.12% | |
| 132 | —PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | $1.1B | 11.86% | |
| 133 | —COGENTIX MED INC | 990,745 | $1.1B | 11.47% | |
| 134 | —BIOLINERX LTD | 1,038,600 | $1.1B | 11.14% | |
| 135 | —QLT INC | 500,000 | $995.0M | 10.47% | |
| 136 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $594.0M | 6.25% | |
| 137 | —BIOMARIN PHARMACEUTICAL INC | 500,000 | $579.0M | 6.09% | |
| 138 | AMRNAMARIN CORP PLC | 350,000 | $536.0M | 5.64% |
PreviousPage 2 of 2